What ABIOMED INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Thomas Paul | Director | Dec 22 | Disposition to Issuer · D | −6,357 | — | — | 0 |
| Johnson Paula A | Director | Dec 22 | Disposition to Issuer · D | −1,659 | — | — | 0 |
| Began Marc A | VP & GENERAL COUNSEL | Dec 22 | Disposition to Issuer · D | −12,237 | — | — | 0 |
| Minogue Michael R | CHAIRMAN, PRESIDENT, CEO | Dec 22 | Disposition to Issuer · D | −243,962 | — | — | 0 |
| Minogue Michael R | CHAIRMAN, PRESIDENT, CEO | Dec 22 | Disposition to Issuer · D | −166,670 | — | — | 0 |
| Sutter Martin P | Director | Dec 22 | Disposition to Issuer · D | −123,370 | — | — | 0 |
| Greenfield Andrew J | VP, CHIEF COMMERCIAL OFFICER | Dec 22 | Disposition to Issuer · D | −23,484 | — | — | 0 |
| Puhy Dorothy E | Director | Dec 22 | Disposition to Issuer · D | −11,335 | — | — | 0 |
| Puhy Dorothy E | Director | Dec 22 | Disposition to Issuer · D | −3,255 | — | — | 0 |
| Van Gorder Chris | Director | Dec 22 | Grant / award · A | +7,410 | — | — | 0 |
| Trapp Todd A | VICE PRESIDENT, CFO | Dec 22 | Disposition to Issuer · D | −14,166 | — | — | 0 |
| Rolle Myron L | Director | Dec 22 | Disposition to Issuer · D | −1,721 | — | — | 0 |
| Plano Matthew T. | VP, GLOBAL OPERATIONS | Dec 22 | Disposition to Issuer · D | −8,406 | — | — | 0 |
| Minogue Michael R | CHAIRMAN, PRESIDENT, CEO | Dec 16 | Grant / award · A | +1 | — | — | 136,086 |
| Greenfield Andrew J | VP, CHIEF COMMERCIAL OFFICER | Dec 16 | Grant / award · A | +14 | — | — | 15,977 |
| Sutter Martin P | Director | Nov 16 | Open-market sale · S | −141 | $375.56 | −$53K | 119,370 |
| Sutter Martin P | Director | Nov 16 | Open-market sale · S | −1,859 | $374.66 | −$696K | 119,511 |
| Sutter Martin P | Director | Nov 15 | Open-market sale · S | −867 | $374.92 | −$325K | 121,370 |
| Sutter Martin P | Director | Nov 15 | Open-market sale · S | −1,133 | $374.18 | −$424K | 122,237 |
| Minogue Michael R | CHAIRMAN, PRESIDENT, CEO | Nov 05 | Withheld — tax / exercise cost · F | −5,164 | $373.99 | −$1.93M | 248,146 |
Loading...
